Cargando…

High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank

OBJECTIVE: High-density lipoproteins (HDL) comprise particles of different size, density and composition and their vasoprotective functions may differ. Diabetes modifies the composition and function of HDL. We assessed associations of HDL size-based subclasses with incident cardiovascular disease (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Qiao, Lau, Eric S. H., Luk, Andrea O., Tam, Claudia H. T., Ozaki, Risa, Lim, Cadmon K. P., Wu, Hongjiang, Chow, Elaine Y. K., Kong, Alice P. S., Lee, Heung Man, Fan, Baoqi, Ng, Alex C. W., Jiang, Guozhi, Lee, Ka Fai, Siu, Shing Chung, Hui, Grace, Tsang, Chiu Chi, Lau, Kam Piu, Leung, Jenny Y., Tsang, Man-wo, Cheung, Elaine Y. N., Kam, Grace, Lau, Ip Tim, Li, June K., Yeung, Vincent T., Lau, Emmy, Lo, Stanley, Fung, Samuel, Cheng, Yuk Lun, Chow, Chun Chung, Yu, Weichuan, Tsui, Stephen K. W., Huang, Yu, Lan, Hui-yao, Szeto, Cheuk Chun, So, Wing Yee, Jenkins, Alicia J., Chan, Juliana C. N., Ma, Ronald C. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805680/
https://www.ncbi.nlm.nih.gov/pubmed/36587202
http://dx.doi.org/10.1186/s12933-022-01726-y
_version_ 1784862380817121280
author Jin, Qiao
Lau, Eric S. H.
Luk, Andrea O.
Tam, Claudia H. T.
Ozaki, Risa
Lim, Cadmon K. P.
Wu, Hongjiang
Chow, Elaine Y. K.
Kong, Alice P. S.
Lee, Heung Man
Fan, Baoqi
Ng, Alex C. W.
Jiang, Guozhi
Lee, Ka Fai
Siu, Shing Chung
Hui, Grace
Tsang, Chiu Chi
Lau, Kam Piu
Leung, Jenny Y.
Tsang, Man-wo
Cheung, Elaine Y. N.
Kam, Grace
Lau, Ip Tim
Li, June K.
Yeung, Vincent T.
Lau, Emmy
Lo, Stanley
Fung, Samuel
Cheng, Yuk Lun
Chow, Chun Chung
Yu, Weichuan
Tsui, Stephen K. W.
Huang, Yu
Lan, Hui-yao
Szeto, Cheuk Chun
So, Wing Yee
Jenkins, Alicia J.
Chan, Juliana C. N.
Ma, Ronald C. W.
author_facet Jin, Qiao
Lau, Eric S. H.
Luk, Andrea O.
Tam, Claudia H. T.
Ozaki, Risa
Lim, Cadmon K. P.
Wu, Hongjiang
Chow, Elaine Y. K.
Kong, Alice P. S.
Lee, Heung Man
Fan, Baoqi
Ng, Alex C. W.
Jiang, Guozhi
Lee, Ka Fai
Siu, Shing Chung
Hui, Grace
Tsang, Chiu Chi
Lau, Kam Piu
Leung, Jenny Y.
Tsang, Man-wo
Cheung, Elaine Y. N.
Kam, Grace
Lau, Ip Tim
Li, June K.
Yeung, Vincent T.
Lau, Emmy
Lo, Stanley
Fung, Samuel
Cheng, Yuk Lun
Chow, Chun Chung
Yu, Weichuan
Tsui, Stephen K. W.
Huang, Yu
Lan, Hui-yao
Szeto, Cheuk Chun
So, Wing Yee
Jenkins, Alicia J.
Chan, Juliana C. N.
Ma, Ronald C. W.
author_sort Jin, Qiao
collection PubMed
description OBJECTIVE: High-density lipoproteins (HDL) comprise particles of different size, density and composition and their vasoprotective functions may differ. Diabetes modifies the composition and function of HDL. We assessed associations of HDL size-based subclasses with incident cardiovascular disease (CVD) and mortality and their prognostic utility. RESEARCH DESIGN AND METHODS: HDL subclasses by nuclear magnetic resonance spectroscopy were determined in sera from 1991 fasted adults with type 2 diabetes (T2D) consecutively recruited from March 2014 to February 2015 in Hong Kong. HDL was divided into small, medium, large and very large subclasses. Associations (per SD increment) with outcomes were evaluated using multivariate Cox proportional hazards models. C-statistic, integrated discrimination index (IDI), and categorial and continuous net reclassification improvement (NRI) were used to assess predictive value. RESULTS: Over median (IQR) 5.2 (5.0–5.4) years, 125 participants developed incident CVD and 90 participants died. Small HDL particles (HDL-P) were inversely associated with incident CVD [hazard ratio (HR) 0.65 (95% CI 0.52, 0.81)] and all-cause mortality [0.47 (0.38, 0.59)] (false discovery rate < 0.05). Very large HDL-P were positively associated with all-cause mortality [1.75 (1.19, 2.58)]. Small HDL-P improved prediction of mortality [C-statistic 0.034 (0.013, 0.055), IDI 0.052 (0.014, 0.103), categorical NRI 0.156 (0.006, 0.252), and continuous NRI 0.571 (0.246, 0.851)] and CVD [IDI 0.017 (0.003, 0.038) and continuous NRI 0.282 (0.088, 0.486)] over the RECODe model. CONCLUSION: Small HDL-P were inversely associated with incident CVD and all-cause mortality and improved risk stratification for adverse outcomes in people with T2D. HDL-P may be used as markers for residual risk in people with T2D. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01726-y.
format Online
Article
Text
id pubmed-9805680
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98056802023-01-02 High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank Jin, Qiao Lau, Eric S. H. Luk, Andrea O. Tam, Claudia H. T. Ozaki, Risa Lim, Cadmon K. P. Wu, Hongjiang Chow, Elaine Y. K. Kong, Alice P. S. Lee, Heung Man Fan, Baoqi Ng, Alex C. W. Jiang, Guozhi Lee, Ka Fai Siu, Shing Chung Hui, Grace Tsang, Chiu Chi Lau, Kam Piu Leung, Jenny Y. Tsang, Man-wo Cheung, Elaine Y. N. Kam, Grace Lau, Ip Tim Li, June K. Yeung, Vincent T. Lau, Emmy Lo, Stanley Fung, Samuel Cheng, Yuk Lun Chow, Chun Chung Yu, Weichuan Tsui, Stephen K. W. Huang, Yu Lan, Hui-yao Szeto, Cheuk Chun So, Wing Yee Jenkins, Alicia J. Chan, Juliana C. N. Ma, Ronald C. W. Cardiovasc Diabetol Research OBJECTIVE: High-density lipoproteins (HDL) comprise particles of different size, density and composition and their vasoprotective functions may differ. Diabetes modifies the composition and function of HDL. We assessed associations of HDL size-based subclasses with incident cardiovascular disease (CVD) and mortality and their prognostic utility. RESEARCH DESIGN AND METHODS: HDL subclasses by nuclear magnetic resonance spectroscopy were determined in sera from 1991 fasted adults with type 2 diabetes (T2D) consecutively recruited from March 2014 to February 2015 in Hong Kong. HDL was divided into small, medium, large and very large subclasses. Associations (per SD increment) with outcomes were evaluated using multivariate Cox proportional hazards models. C-statistic, integrated discrimination index (IDI), and categorial and continuous net reclassification improvement (NRI) were used to assess predictive value. RESULTS: Over median (IQR) 5.2 (5.0–5.4) years, 125 participants developed incident CVD and 90 participants died. Small HDL particles (HDL-P) were inversely associated with incident CVD [hazard ratio (HR) 0.65 (95% CI 0.52, 0.81)] and all-cause mortality [0.47 (0.38, 0.59)] (false discovery rate < 0.05). Very large HDL-P were positively associated with all-cause mortality [1.75 (1.19, 2.58)]. Small HDL-P improved prediction of mortality [C-statistic 0.034 (0.013, 0.055), IDI 0.052 (0.014, 0.103), categorical NRI 0.156 (0.006, 0.252), and continuous NRI 0.571 (0.246, 0.851)] and CVD [IDI 0.017 (0.003, 0.038) and continuous NRI 0.282 (0.088, 0.486)] over the RECODe model. CONCLUSION: Small HDL-P were inversely associated with incident CVD and all-cause mortality and improved risk stratification for adverse outcomes in people with T2D. HDL-P may be used as markers for residual risk in people with T2D. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01726-y. BioMed Central 2022-12-31 /pmc/articles/PMC9805680/ /pubmed/36587202 http://dx.doi.org/10.1186/s12933-022-01726-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jin, Qiao
Lau, Eric S. H.
Luk, Andrea O.
Tam, Claudia H. T.
Ozaki, Risa
Lim, Cadmon K. P.
Wu, Hongjiang
Chow, Elaine Y. K.
Kong, Alice P. S.
Lee, Heung Man
Fan, Baoqi
Ng, Alex C. W.
Jiang, Guozhi
Lee, Ka Fai
Siu, Shing Chung
Hui, Grace
Tsang, Chiu Chi
Lau, Kam Piu
Leung, Jenny Y.
Tsang, Man-wo
Cheung, Elaine Y. N.
Kam, Grace
Lau, Ip Tim
Li, June K.
Yeung, Vincent T.
Lau, Emmy
Lo, Stanley
Fung, Samuel
Cheng, Yuk Lun
Chow, Chun Chung
Yu, Weichuan
Tsui, Stephen K. W.
Huang, Yu
Lan, Hui-yao
Szeto, Cheuk Chun
So, Wing Yee
Jenkins, Alicia J.
Chan, Juliana C. N.
Ma, Ronald C. W.
High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank
title High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank
title_full High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank
title_fullStr High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank
title_full_unstemmed High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank
title_short High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank
title_sort high-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the hong kong diabetes biobank
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805680/
https://www.ncbi.nlm.nih.gov/pubmed/36587202
http://dx.doi.org/10.1186/s12933-022-01726-y
work_keys_str_mv AT jinqiao highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT lauericsh highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT lukandreao highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT tamclaudiaht highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT ozakirisa highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT limcadmonkp highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT wuhongjiang highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT chowelaineyk highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT kongaliceps highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT leeheungman highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT fanbaoqi highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT ngalexcw highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT jiangguozhi highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT leekafai highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT siushingchung highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT huigrace highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT tsangchiuchi highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT laukampiu highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT leungjennyy highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT tsangmanwo highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT cheungelaineyn highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT kamgrace highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT lauiptim highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT lijunek highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT yeungvincentt highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT lauemmy highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT lostanley highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT fungsamuel highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT chengyuklun highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT chowchunchung highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT yuweichuan highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT tsuistephenkw highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT huangyu highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT lanhuiyao highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT szetocheukchun highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT sowingyee highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT jenkinsaliciaj highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT chanjulianacn highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT maronaldcw highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank
AT highdensitylipoproteinsubclassesandcardiovasculardiseaseandmortalityintype2diabetesanalysisfromthehongkongdiabetesbiobank